Caption Management’s Immunocore IMCR Stock Holding History

Caption Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$905K	Buy	+30,000	New	+$971K	0.01%	1052
2025 Q4	–	Sell	-64,400	Closed	-$2.34M	–	1811
2025 Q3	$2.34M	Buy	+64,400	New	+$2.19M	0.02%	784
2025 Q2	–	Sell	-27,500	Closed	-$816K	–	1669
2025 Q1	$816K	Buy	+27,500	New	+$825K	0.01%	974
2024 Q4	–	Sell	-12,500	Closed	-$389K	–	1624
2024 Q3	$389K	Buy	+12,500	New	+$455K	0.01%	971
2024 Q2	–	Sell	-162,000	Closed	-$10.5M	–	1321
2024 Q1	$10.5M	Buy	+162,000	New	+$11.1M	0.16%	152

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Caption Management's IMCR Position: Q1 2026 in Review

Caption Management increased its Immunocore (IMCR) stake by 601% in Q1 2026, buying an estimated $18.4M and bringing the position to 661,786 shares worth $20M. The position accounts for 0.12% of the portfolio, ranked #188.

Caption Management first reported a position in IMCR in Q4 2022 and has held it in 7 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Caption Management held 661,786 shares of Immunocore worth $20M as of Q1 2026.
Caption Management bought 567,402 Immunocore shares in Q1 2026, an estimated $18.4M.
Immunocore made up 0.12% of Caption Management's portfolio in Q1 2026, its #188 holding.
Caption Management first reported a position in Immunocore in Q4 2022 and has held it in 7 quarters since.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.